Surfactant Therapy and Intravenous Zanamivir in Severe Respiratory Failure Due to Persistent Influenza A/H1N1 2009 Virus Infection
Stefano Busani(University of Modena and Reggio Emilia), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Alberto Pasetto(University of Modena and Reggio Emilia), Massimo Girardis(University of Modena and Reggio Emilia), Emanuela Biagioni(University of Modena and Reggio Emilia)
American Journal of Respiratory and Critical Care Medicine
November 1, 2010
Cited by 10
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
Early vs Late Tracheotomy for Prevention of Pneumonia in Mechanically Ventilated Adult ICU Patients
|JAMA|2010|542
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404